-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Regulatory Perspective

Program: Special-Interest Sessions
Session: Special Scientific Session on Race and Science: Bench to Bedside to the Community
Sunday, December 10, 2023, 9:30 AM-11:00 AM

Nicole Gormley, MD

Division of Hematologic Malignancies II, Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD

Disclosures: No relevant conflicts of interest to declare.